Stroke features and management in patients with chronic kidney disease

Research output: Chapter in Book/Report/Conference proceedingChapter

10 Citations (Scopus)

Abstract

Chronic kidney disease (CKD) is an independent risk factor for cardiovascular diseases, including stroke. Patients with CKD are susceptible to ischemic as well as hemorrhagic stroke. The impairments in the small vessel vasculature, atherosclerotic changes of the large vessels, and coagulation abnormalities in CKD probably underlie the specific characteristics of stroke in these patients. The clinical outcomes, including the functional outcomes and short- as well as long-term mortality after stroke, are poor in patients with CKD. CKD is defined as a decreased glomerular filtration rate (GFR) and/or increased urine albumin excretion. A number of studies have shown that either or both of these two markers were significantly associated with poor functional outcomes and mortality after stroke. Recent studies have suggested that proteinuria/albuminuria is more deeply involved in the clinical outcomes than GFR. Although the mechanisms responsible for their association are currently unclear, glomerular barrier and/or filtration dysfunction are probably related to the small vessel diseases, hypercoagulability and inflammation, which may affect the clinical outcomes in CKD patients after stroke. The evidence for the most effective management of acute stroke in CKD patients is lacking, and thus, the current treatment for stroke is optimized for individual patients based on their background. Further studies are thus needed to elucidate the specific features of stroke and also the management of stroke in patients with CKD.

Original languageEnglish
Title of host publicationBrain, Stroke and Kidney
EditorsKazunori Toyoda
Pages92-99
Number of pages8
DOIs
Publication statusPublished - May 27 2013

Publication series

NameContributions to Nephrology
Volume179
ISSN (Print)0302-5144

Fingerprint

Chronic Renal Insufficiency
Stroke
Glomerular Filtration Rate
Glomerular Filtration Barrier
Albuminuria
Thrombophilia
Mortality
Proteinuria
Albumins
Cardiovascular Diseases
Urine
Inflammation

All Science Journal Classification (ASJC) codes

  • Nephrology

Cite this

Kamouchi, M. (2013). Stroke features and management in patients with chronic kidney disease. In K. Toyoda (Ed.), Brain, Stroke and Kidney (pp. 92-99). (Contributions to Nephrology; Vol. 179). https://doi.org/10.1159/000346727

Stroke features and management in patients with chronic kidney disease. / Kamouchi, Masahiro.

Brain, Stroke and Kidney. ed. / Kazunori Toyoda. 2013. p. 92-99 (Contributions to Nephrology; Vol. 179).

Research output: Chapter in Book/Report/Conference proceedingChapter

Kamouchi, M 2013, Stroke features and management in patients with chronic kidney disease. in K Toyoda (ed.), Brain, Stroke and Kidney. Contributions to Nephrology, vol. 179, pp. 92-99. https://doi.org/10.1159/000346727
Kamouchi M. Stroke features and management in patients with chronic kidney disease. In Toyoda K, editor, Brain, Stroke and Kidney. 2013. p. 92-99. (Contributions to Nephrology). https://doi.org/10.1159/000346727
Kamouchi, Masahiro. / Stroke features and management in patients with chronic kidney disease. Brain, Stroke and Kidney. editor / Kazunori Toyoda. 2013. pp. 92-99 (Contributions to Nephrology).
@inbook{0e49fcd1a4c149ecafcc964031adc353,
title = "Stroke features and management in patients with chronic kidney disease",
abstract = "Chronic kidney disease (CKD) is an independent risk factor for cardiovascular diseases, including stroke. Patients with CKD are susceptible to ischemic as well as hemorrhagic stroke. The impairments in the small vessel vasculature, atherosclerotic changes of the large vessels, and coagulation abnormalities in CKD probably underlie the specific characteristics of stroke in these patients. The clinical outcomes, including the functional outcomes and short- as well as long-term mortality after stroke, are poor in patients with CKD. CKD is defined as a decreased glomerular filtration rate (GFR) and/or increased urine albumin excretion. A number of studies have shown that either or both of these two markers were significantly associated with poor functional outcomes and mortality after stroke. Recent studies have suggested that proteinuria/albuminuria is more deeply involved in the clinical outcomes than GFR. Although the mechanisms responsible for their association are currently unclear, glomerular barrier and/or filtration dysfunction are probably related to the small vessel diseases, hypercoagulability and inflammation, which may affect the clinical outcomes in CKD patients after stroke. The evidence for the most effective management of acute stroke in CKD patients is lacking, and thus, the current treatment for stroke is optimized for individual patients based on their background. Further studies are thus needed to elucidate the specific features of stroke and also the management of stroke in patients with CKD.",
author = "Masahiro Kamouchi",
year = "2013",
month = "5",
day = "27",
doi = "10.1159/000346727",
language = "English",
isbn = "9783318023510",
series = "Contributions to Nephrology",
pages = "92--99",
editor = "Kazunori Toyoda",
booktitle = "Brain, Stroke and Kidney",

}

TY - CHAP

T1 - Stroke features and management in patients with chronic kidney disease

AU - Kamouchi, Masahiro

PY - 2013/5/27

Y1 - 2013/5/27

N2 - Chronic kidney disease (CKD) is an independent risk factor for cardiovascular diseases, including stroke. Patients with CKD are susceptible to ischemic as well as hemorrhagic stroke. The impairments in the small vessel vasculature, atherosclerotic changes of the large vessels, and coagulation abnormalities in CKD probably underlie the specific characteristics of stroke in these patients. The clinical outcomes, including the functional outcomes and short- as well as long-term mortality after stroke, are poor in patients with CKD. CKD is defined as a decreased glomerular filtration rate (GFR) and/or increased urine albumin excretion. A number of studies have shown that either or both of these two markers were significantly associated with poor functional outcomes and mortality after stroke. Recent studies have suggested that proteinuria/albuminuria is more deeply involved in the clinical outcomes than GFR. Although the mechanisms responsible for their association are currently unclear, glomerular barrier and/or filtration dysfunction are probably related to the small vessel diseases, hypercoagulability and inflammation, which may affect the clinical outcomes in CKD patients after stroke. The evidence for the most effective management of acute stroke in CKD patients is lacking, and thus, the current treatment for stroke is optimized for individual patients based on their background. Further studies are thus needed to elucidate the specific features of stroke and also the management of stroke in patients with CKD.

AB - Chronic kidney disease (CKD) is an independent risk factor for cardiovascular diseases, including stroke. Patients with CKD are susceptible to ischemic as well as hemorrhagic stroke. The impairments in the small vessel vasculature, atherosclerotic changes of the large vessels, and coagulation abnormalities in CKD probably underlie the specific characteristics of stroke in these patients. The clinical outcomes, including the functional outcomes and short- as well as long-term mortality after stroke, are poor in patients with CKD. CKD is defined as a decreased glomerular filtration rate (GFR) and/or increased urine albumin excretion. A number of studies have shown that either or both of these two markers were significantly associated with poor functional outcomes and mortality after stroke. Recent studies have suggested that proteinuria/albuminuria is more deeply involved in the clinical outcomes than GFR. Although the mechanisms responsible for their association are currently unclear, glomerular barrier and/or filtration dysfunction are probably related to the small vessel diseases, hypercoagulability and inflammation, which may affect the clinical outcomes in CKD patients after stroke. The evidence for the most effective management of acute stroke in CKD patients is lacking, and thus, the current treatment for stroke is optimized for individual patients based on their background. Further studies are thus needed to elucidate the specific features of stroke and also the management of stroke in patients with CKD.

UR - http://www.scopus.com/inward/record.url?scp=84926097889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926097889&partnerID=8YFLogxK

U2 - 10.1159/000346727

DO - 10.1159/000346727

M3 - Chapter

C2 - 23652452

AN - SCOPUS:84926097889

SN - 9783318023510

T3 - Contributions to Nephrology

SP - 92

EP - 99

BT - Brain, Stroke and Kidney

A2 - Toyoda, Kazunori

ER -